Literature DB >> 6609995

Rescue of the tumor-specific immune response of aged mice in vitro.

J L Urban, H Schreiber.   

Abstract

In contrast to young mice, old mice fail to reject a transplanted challenge of the highly immunogenic, ultraviolet light-induced tumor 1591-RE. Old mice also fail to mount a cytolytic tumor-specific immune response in vivo, and spleen cells of old mice are defective in their ability to generate tumor-specific T cells in vitro. In the present study we report the results of cell culture mixing experiments that show that this deficiency is due to a decreased responsiveness of the Lyt-2+ tumor-specific cytolytic T cell precursors of the old animals. We also demonstrate with limiting dilution analysis that the defective responsiveness is not due to a clonal exhaustion of the precursors. In fact, the responsiveness could be restored in vitro by culturing the spleen cells of old animals at high density or by the addition of excess Lyt-1-/Lyt-2-/2000-rad-resistant spleen cells from young or old mice. Our results suggest that the rescue of tumor immunity in old individuals may be possible, perhaps by educating effector cells in vitro for adoptive immunotherapy.

Entities:  

Mesh:

Year:  1984        PMID: 6609995

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Effect of advanced ageing on the ability of mice to cause tumour regression in response to immunotherapy.

Authors:  P L Dunn; R J North
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

2.  Long-term immunological memory in the resistance of rats to transplanted intracerebral 9L gliosarcoma (9LGS) following subcutaneous immunization with 9LGS cells.

Authors:  H M Smilowitz; D D Joel; D N Slatkin; P L Micca; M M Nawrocky; K Youngs; W Tu; J A Coderre
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

3.  Host age is a systemic regulator of gene expression impacting cancer progression.

Authors:  Afshin Beheshti; Sébastien Benzekry; J Tyson McDonald; Lili Ma; Michael Peluso; Philip Hahnfeldt; Lynn Hlatky
Journal:  Cancer Res       Date:  2015-03-02       Impact factor: 12.701

Review 4.  Optimization of immunotherapy in elderly cancer patients.

Authors:  Kei Tomihara; Tyler J Curiel; Bin Zhang
Journal:  Crit Rev Oncog       Date:  2013

5.  Development of effective vaccines for old mice in a tumor model.

Authors:  David N Posnett; Manuel E Engelhorn; Yun Lin; Taha Merghoub; Fei Duan; Jedd D Wolchok; Alan N Houghton
Journal:  Vaccine       Date:  2008-12-25       Impact factor: 3.641

6.  Effect of advanced aging on ability of mice to cause regression of an immunogenic lymphoma in response to immunotherapy based on depletion of suppressor T cells.

Authors:  P L Dunn; R J North
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Defective T helper activity in the spleen of BALB/c mice immune to a syngeneic fibrosarcoma.

Authors:  L Grazioli; M Sensi; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

8.  Tumor growth and evasion of immune destruction: UV-induced tumors as a model.

Authors:  C A Mullen; H Schreiber
Journal:  Surv Immunol Res       Date:  1985

Review 9.  Is There a Positive Side to T Cell Exhaustion?

Authors:  Graham Pawelec
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.